Healthcare Providers’ Perspectives on Telemedicine for NCD Management During and After COVID-19 in India: A Qualitative Study
Highlights
- Telemedicine played a crucial role in sustaining non-communicable disease (NCD) care during the COVID-19 pandemic in India.
- Healthcare providers’ experiences provide insights into the real-world use of telemedicine in resource-limited settings such as those with poor internet, staff shortages, limited time, or low digital skills.
- This study provides qualitative evidence on the system-level, technological, and clinical challenges affecting the long-term integration of telemedicine into routine NCD care.
- Provider-recommended strategies, including workflow restructuring, digital literacy strengthening, and hybrid care models, align with national digital health goals.
- Addressing infrastructure gaps, improving digital competencies, and incorporating video-enabled and hybrid models are essential for sustainable telemedicine adoption.
- Future digital health policies and research should incorporate provider insights and follow patients over time, using mixed-method approaches to ensure equitable and resilient NCD care delivery.
Abstract
1. Introduction
2. Methodology
2.1. Study Design
2.2. Sampling and Recruitment
2.3. Data Collection
2.4. Interview Procedure
2.5. Bias Mitigation Strategies
2.6. Data Analysis
3. Results
3.1. Thematic Analysis
3.2. Theme 1: Perceived Benefits and Satisfaction with Telemedicine
3.2.1. Access, Affordability, and Time–Cost Efficiency
“For middle and lower socioeconomic statuses, daily wages matter a lot when coming to the healthcare system; taking consultation and one day’s wages is curtailed, is cut down. So, regarding this point and also the difficulty in coming, getting a consultation, and wasting a whole day is not affordable for all people. So, for follow-up services, telemedicine can be a good additional point apart from traditional consultation” (P07).
3.2.2. Continuity of Care During the COVID-19
3.2.3. Psychological Reassurance and Perceived Support
“Seeing the covid situation. It had more pros than cons; health was the top priority, and being able to talk to a doctor during such a crisis wasn’t just about managing the disease, it also gave patients a lot of psychological relief. Just knowing they could reach out and get guidance really helped ease their worries” (P021).
3.2.4. Provider Satisfaction with Telemedicine
“Telemedicine has been extremely beneficial, be it COVID or non-COVID times. It provides ease of consultation, so I would rate it 9 out of 10” (P17).
3.3. Theme 2: Challenges in Telemedicine Use
3.3.1. Clinical Limitations
“We couldn’t see the patients. We couldn’t touch the patients; direct physical examination was not possible, right? So, it is the major challenge” (P11).
“It is very difficult to initially diagnose the patient, but for the follow-up, it is very good, but for the initial check on examination and for history taking, it is very difficult in telemedicine” (P08).
3.3.2. Technological and Infrastructure Barriers
“First of all, the awareness is lacking among people; 80% of people don’t know. Also, to avail this service, you need to have strong internet or infrastructure. In rural areas we still lack internet; there is a lot to be done in these areas” (P032).
“We do have telemedicine; the visual is not available here. Visual things face-to-face—if it is available, it will be good; it will be better to consult them. With their reaction facial expressions, we can catch some problems” (P11).
3.3.3. Digital Literacy and Heterogenous Awareness
“So, most of the patients, like if you see, among a hundred patients, 60 or 70 will be more than 60 years of age. So, accessing mobile phones and accessing video conferencing apps is difficult for them” (P06).
“From the patient side, especially elderly patients prefer face-to-face visits because they want to discuss more things apart from their medical condition, and online consultations often feel less personal and are of short duration, like 2–3 min, and can leave patients unsatisfied” (P14).
“As far as India is concerned, we are basically dealing with the poor class; most of them are not aware of telemedicine” (P02).
3.3.4. System-Level and Scheduling Constraints
“We are working for a certain period of time; the patient is also working. So, they will be wanting a time maybe before or after that certain time, like in the morning or after evening, so technically that is not possible for us” (P028).
3.3.5. Data Safety, Privacy, and Regulatory Concerns
“My patients did not, per se, mention anything about this. They do trust their doctors where they are sending the information. So, I don’t think that they have this notion that their data would be used in some other way” (P23).
“Well, what are the exact guidelines? I’m not very well aware of what the exact guidelines are” (P31).
3.4. Theme 3: Impact of COVID-19 on Non-Communicable Diseases
3.4.1. New-Onset NCDs Following COVID-19 Infection
“There are a greater number of cases of non-communicable disease. We find blood pressure at an early age. We find heart involvement at an early age. We find lung damage at an early age. This thing normally occurs internationally after the age of 60 years in India. These occur after the age of 40 years. But even now because of post-COVID, we are seeing these cases after the age of 30 years” (P02).
3.4.2. Exacerbation of Pre-Existing NCDs Post-COVID
“People are having respiratory problems; COPD is quite high. They are not getting relieved by whatever conventional method we have. Similarly, the hypertension is going up. Cardiovascular disease is also going up. The strokes are going up, and joint issues, the pain, and the weakness are also going up. Then we have cancers, which are also going up” (P04).
3.4.3. Continuity of Care in Managing NCDs During and After COVID-19
“We are more focused on some lifestyle changes because we have realized that lifestyle interventions have had a lot of effect on the management of NCD patients. So, lifestyle changes, such as dietary habits, exercise, yoga, and meditation, have created such a positive change” (P07).
3.5. Theme 4: Optimizing Digital Health and Telemedicine for NCD Care
3.5.1. System-Level Organization and Workflow Integration
“Doctors should be trained in how to use this spectrum. Maybe if they have 8 or 10 h a day, we can have two hours only for teleconsultation so that the patient load that they are handling in OPDs as well as in patients can be avoided” (P17).
3.5.2. Capacity Building and Enhancing Awareness
“Doctors should be trained in how to use this spectrum” (P17).
“The only thing I feel is awareness, like the government has launched many digital platforms, but people are not aware, and if they are aware, how will they use them? Increasing awareness, be it through social media or video or man-to-man, but it should be there for better utilization of resources” (P30).
3.5.3. Integration of Advanced Digital Technologies
“The telemedicine role will increase in the future. With artificial intelligence coming in, we can improvise this telemedicine. Something like you can monitor a patient at different times in 1 h, 2 h, or while sitting in the hospital; with AI facilities, these things will be taken care of” (P19).
3.5.4. Telemedicine for Prevention and Health Promotion
“Making them aware about active lifestyles along with proper diet information or food habits can prevent them from getting NCDs in younger age groups, and this can be achieved through telemedicine” (P20).
4. Discussion
Limitations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
| MBBS | Bachelor of Medicine and Bachelor of Surgery |
| MD | Doctor of Medicine |
| BDS | Bachelor of Dental Surgery |
| MDS | Master of Dental Surgery |
| BAMS | Bachelor of Ayurvedic Medicine & Surgery |
| BHMS | Bachelor of Homeopathic Medicine & Surgery |
| BUMS | Bachelor of Unani Medicine & Surgery |
| BSMS | Bachelor of Siddha Medicine & Surgery |
| Ph.D. | Doctor of Philosophy |
| MPH | Master in Public Health |
| PHCs | Primary Health Centre |
| AYUSH | Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homeopathy |
| WHO | World Health Organization |
| NCD | Non-communicable diseases |
| NDHM | National Digital Health Mission |
| COREQ | Consolidated Criteria for Reporting Qualitative Research |
| ABDM | Ayushman Bharat Digital Mission |
References
- Omotayo, O.; Maduka, C.P.; Muonde, M.; Olorunsogo, T.O.; Ogugua, J.O. The rise of non-communicable diseases: A global health review of challenges and prevention strategies. Int. Med. Sci. Res. J. 2024, 4, 74–88. [Google Scholar] [CrossRef]
- Buhmeida, A.; Assidi, M.; Budowle, B. Current Healthcare Systems in Light of Hyperendemic NCDs and the COVID-19 Pandemic: Time to Change. Healthcare 2023, 11, 1382. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. Noncommunicable Diseases. Available online: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases (accessed on 1 September 2025).
- Pradhan, J.; Pai, M.; Dwivedi, R.; Mishra, B.; Behera, S.; Bera, T.; Kim, R.; Subramanian, S.V. Burden of Non-Communicable Diseases in South Asia: A Decomposition Analysis. J. Health Popul. Nutr. 2025, 44, 124. [Google Scholar] [CrossRef] [PubMed]
- Shu, J.; Jin, W. Prioritizing Non-Communicable Diseases in the Post-Pandemic Era Based on a Comprehensive Analysis of the GBD 2019 from 1990 to 2019. Sci. Rep. 2023, 13, 13325. [Google Scholar] [CrossRef]
- Anjana, R.M.; Unnikrishnan, R.; Deepa, M.; Pradeepa, R.; Tandon, N.; Das, A.K.; Joshi, S.; Bajaj, S.; Jabbar, P.K.; Das, H.K.; et al. Metabolic Non-Communicable Disease Health Report of India: The ICMR-INDIAB National Cross-Sectional Study (ICMR-INDIAB-17). Lancet Diabetes Endocrinol. 2023, 11, 474–489. [Google Scholar] [CrossRef]
- Budreviciute, A.; Damiati, S.; Sabir, D.K.; Onder, K.; Schuller-Goetzburg, P.; Plakys, G.; Katileviciute, A.; Khoja, S.; Kodzius, R. Management and Prevention Strategies for Non-Communicable Diseases (NCDs) and Their Risk Factors. Front. Public Health 2020, 8, 574111. [Google Scholar] [CrossRef]
- Siddiqui, F.; Hewitt, C.; Jennings, H.; Coales, K.; Mazhar, L.; Boeckmann, M.; Siddiqi, N. Self-Management of Chronic, Non-Communicable Diseases in South Asian Settings: A Systematic Mixed-Studies Review. PLoS Glob. Public Health 2024, 4, e0001668. [Google Scholar] [CrossRef]
- Altabtabaei, R.; Alhuwail, D. Exploring the Challenges and Opportunities of Adopting and Using Telemedicine for Diabetes Care and Management: Qualitative Semistructured Interview Study Among Health Care Providers and Patients with Diabetes. JMIR Hum. Factors 2023, 10, e46324. [Google Scholar] [CrossRef]
- Kara, S.A.; Cakir, B. Management of Non-Communicable Disease Patients during the COVID-19 Pandemic. J. Public Health Emerg. 2025, 9, 18. [Google Scholar] [CrossRef]
- Haridoss, M.; Nandi, D.; Rajesh Lenin, R.; John, S.P.; Anantharaman, V.V.; Janardhanan, R. Health-Seeking Behavior and Its Determinants for Non-Communicable Diseases in India—A Systematic Review and Meta-Analysis. Front. Public Health 2025, 13, 1580824. [Google Scholar] [CrossRef]
- Anawade, P.A.; Sharma, D.; Gahane, S. A Comprehensive Review on Exploring the Impact of Telemedicine on Healthcare Accessibility. Cureus 2024, 16, e55996. [Google Scholar] [CrossRef]
- Hong, Z.; Li, N.; Li, D.; Li, J.; Li, B.; Xiong, W.; Lu, L.; Li, W.; Zhou, D. Telemedicine During the COVID-19 Pandemic: Experiences From Western China. J. Med. Internet Res. 2020, 22, e19577. [Google Scholar] [CrossRef] [PubMed]
- Digital Health and Innovation (DHI). Recommendations on Digital Interventions for Health System Strengthening. Available online: https://www.who.int/publications/i/item/9789241550505 (accessed on 25 September 2025).
- Kamath, R.; Banu, M.; Shet, N.; Jayapriya, V.R.; Lakshmi Ramesh, V.; Jahangir, S.; Akthar, N.; Brand, H.; Prabhu, V.; Singh, V.; et al. Awareness of and Challenges in Utilizing the Ayushman Bharat Digital Mission for Healthcare Delivery: Qualitative Insights from University Students in Coastal Karnataka in India. Healthcare 2025, 13, 382. [Google Scholar] [CrossRef] [PubMed]
- TIFAC (Technology Information Forecasting and Assessment Council). Current Trends in Telemedicine in India. Available online: https://www.tifac.org.in/index.php/reports-publications/recent-publications/2-uncategorised/1120-current-trends-in-telemedicine-in-india (accessed on 1 September 2025).
- Arora, S.; Huda, R.K.; Verma, S.; Khetan, M.; Sangwan, R.K. Challenges, Barriers, and Facilitators in Telemedicine Implementation in India: A Scoping Review. Cureus 2024, 16, e67388. [Google Scholar] [CrossRef] [PubMed]
- Hennink, M.M.; Kaiser, B.N.; Marconi, V.C. Code Saturation Versus Meaning Saturation: How Many Interviews Are Enough? Qual. Health Res. 2017, 27, 591–608. [Google Scholar] [CrossRef]
- Chen, M.; Zhu, B.; Chen, D.; Hu, X.; Xu, X.; Shen, W.-J.; Hu, C.; Li, J.; Qu, S. COVID-19 May Increase the Risk of Insulin Resistance in Adult Patients Without Diabetes: A 6-Month Prospective Study. Endocr. Pract. 2021, 27, 834–841. [Google Scholar] [CrossRef]
- Zhou, J.; Wang, Y.; Xu, R. Association of COVID-19 Infection and the Risk of New Incident Diabetes: A Systematic Review and Meta-Analysis. Front. Endocrinol. 2024, 15, 1429848. [Google Scholar] [CrossRef]
- Chen, X.; Lin, H.; Wu, Y.; Wang, M.; Lin, S.; Huang, J. The Impact of the COVID-19 Pandemic on the Global Burden of Type 2 Diabetes: A Study Based on GBD 2021 Data. Front. Endocrinol. 2025, 16, 1600333. [Google Scholar] [CrossRef]
- Fetters, K.B.; Judge, S.P.; Daar, E.S.; Hatlen, T.J. Burden of Hyperglycemia in Patients Receiving Corticosteroids for Severe COVID-19. Mayo Clin. Proc. Innov. Qual. Outcomes 2022, 6, 484–487. [Google Scholar] [CrossRef]
- Keerthi, B.Y.; Sushmita, G.; Khan, E.A.; Thomas, V.; Cheryala, V.; Shah, C.; Kumar, G.R.; Haritha, V. New Onset Diabetes Mellitus in Post-COVID-19 Patients. J. Fam. Med. Prim. Care 2022, 11, 5961–5968. [Google Scholar] [CrossRef]
- Vyas, P.; Joshi, D.; Sharma, V.; Parmar, M.; Vadodariya, J.; Patel, K.; Modi, G. Incidence and Predictors of Development of New Onset Hypertension Post COVID-19 Disease. Indian Heart J. 2023, 75, 347–351. [Google Scholar] [CrossRef]
- Mithal, A.; Jevalikar, G.; Sharma, R.; Singh, A.; Farooqui, K.J.; Mahendru, S.; Krishnamurthy, A.; Dewan, A.; Budhiraja, S. High Prevalence of Diabetes and Other Comorbidities in Hospitalized Patients with COVID-19 in Delhi, India, and Their Association with Outcomes. Diabetes Metab. Syndr. Clin. Res. Rev. 2021, 15, 169–175. [Google Scholar] [CrossRef] [PubMed]
- Trimarco, V.; Izzo, R.; Pacella, D.; Trama, U.; Manzi, M.V.; Lombardi, A.; Piccinocchi, R.; Gallo, P.; Esposito, G.; Piccinocchi, G.; et al. Incidence of New-Onset Hypertension before, during, and after the COVID-19 Pandemic: A 7-Year Longitudinal Cohort Study in a Large Population. BMC Med. 2024, 22, 127. [Google Scholar] [CrossRef] [PubMed]
- Prameswari, R.D.; Revita, N.C.T.; Angraini, D.A.; Asfarina, I. Epidemiological Analysis of Non-Communicable Diseases Post-Covid Era in Indonesia. Indones. J. Glob. Health Res. 2024, 7, 617–626. [Google Scholar] [CrossRef]
- Gordon Patti, K.; Kohli, P. COVID’s Impact on Non-Communicable Diseases: What We Do Not Know May Hurt Us. Curr. Cardiol. Rep. 2022, 24, 829–837. [Google Scholar] [CrossRef]
- Khunti, K.; Del Prato, S.; Mathieu, C.; Kahn, S.E.; Gabbay, R.A.; Buse, J.B. COVID-19, Hyperglycemia, and New-Onset Diabetes. Diabetes Care 2021, 44, 2645–2655. [Google Scholar] [CrossRef]
- Pogorzelska, K.; Chlabicz, S. Patient Satisfaction with Telemedicine during the COVID-19 Pandemic—A Systematic Review. Int. J. Environ. Environ. Res. Public Health 2022, 19, 6113. [Google Scholar] [CrossRef]
- Saeed, S.; Singhal, M.; Kaur, K.N.; Shannawaz, M.; Koul, A.; Arora, K.; Kumar, B.; Sethiya, N.K.; Hasan, S. Acceptability and Satisfaction of Patients and Providers with Telemedicine During the COVID-19 Pandemic: A Systematic Review. Cureus 2024, 16, e56308. [Google Scholar] [CrossRef]
- Karahbolad, H.; Nasrullah, N. Assessing the Efficiency and Patient Satisfaction of Telemedicine in Managing Chronic Health Conditions. Glob. J. Qual. Saf. Healthc. 2025, 8, 121–126. [Google Scholar] [CrossRef]
- Hoffer-Hawlik, M.A.; Moran, A.E.; Burka, D.; Kaur, P.; Cai, J.; Frieden, T.R.; Gupta, R. Leveraging Telemedicine for Chronic Disease Management in Low- and Middle-Income Countries During COVID-19. Glob. Heart 2020, 15, 63. [Google Scholar] [CrossRef]
- Salsabilla, A.; Azzahra, A.B.; Syafitri, R.I.; Supadmi, W.; Suwantika, A.A. Cost-Effectiveness of Telemedicine in Asia: A Scoping Review. J. Multidiscip. Healthc. 2021, 14, 3587–3596. [Google Scholar] [CrossRef] [PubMed]
- Gomez, T.; Anaya, Y.B.; Shih, K.J.; Tarn, D.M. A Qualitative Study of Primary Care Physicians’ Experiences with Telemedicine During COVID-19. J. Am. Board Fam. Med. 2021, 34, S61–S70. [Google Scholar] [CrossRef] [PubMed]
- Ma, Y.; Zhao, C.; Zhao, Y.; Lu, J.; Jiang, H.; Cao, Y.; Xu, Y. Telemedicine Application in Patients with Chronic Disease: A Systematic Review and Meta-Analysis. BMC Med. Inf. Inform. Decis. Mak. 2022, 22, 105. [Google Scholar] [CrossRef] [PubMed]
- Hoogland, A.I.; Mansfield, J.; Lafranchise, E.A.; Bulls, H.W.; Johnstone, P.A.; Jim, H.S.L. eHealth Literacy in Older Adults with Cancer. J. Geriatr. Oncol. 2020, 11, 1020–1022. [Google Scholar] [CrossRef]
- He, H.; Abdul-Rashid, S.H.; Raja Ghazilla, R.A. Research Trends and Hot Spots in Telemedicine for the Elderly: A Scientometric Analysis. Healthcare 2024, 12, 1853. [Google Scholar] [CrossRef]
- Breton, M.; Sullivan, E.E.; Deville-Stoetzel, N.; McKinstry, D.; DePuccio, M.; Sriharan, A.; Deslauriers, V.; Dong, A.; McAlearney, A.S. Telehealth Challenges during COVID-19 as Reported by Primary Healthcare Physicians in Quebec and Massachusetts. BMC Fam. Pract. 2021, 22, 192. [Google Scholar] [CrossRef]
- Saxena, V.; Misra, P.; Naveen, K.H.; Sumanth, M.M.; Das, A.; Jain, V. Strengthening AYUSH Integration with Preventive Medicine. Indian J. Community Med. 2024, 49, S183–S190. [Google Scholar] [CrossRef]
- Sadiq, I.Z. Lifestyle Medicine as a Modality for Prevention and Management of Chronic Diseases. J. Taibah Univ. Med. Sci. 2023, 18, 1115–1117. [Google Scholar] [CrossRef]
- Nadholta, P.; Kumar, S.; Anand, A. Yoga for Control of Progression in the Early Stage of NCDs. Ann. Neurosci. 2023, 30, 79–83. [Google Scholar] [CrossRef]
- Raj, G.M.; Dananjayan, S.; Agarwal, N. Inception of the Indian Digital Health Mission: Connecting…the…Dots. Health Care Sci. 2023, 2, 345–351. [Google Scholar] [CrossRef]
- Tong, A.; Sainsbury, P.; Craig, J. Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. Int. J. Qual. Health Care 2007, 19, 349–357. [Google Scholar] [CrossRef]
| Health Care Providers (n = 33) | n | n (%) |
|---|---|---|
| Age Group (Years) | ||
| 25–34 | 10 | 30.30% |
| 35–44 | 12 | 36.36% |
| 44–54 | 7 | 21.21% |
| >55 years | 4 | 12.12% |
| Gender | ||
| Female | 17 | 51.51% |
| Male | 16 | 48.48% |
| Education level | ||
| MBBS, MD/MS | 17 | 51.51% |
| BDS, MDS | 1 | 3.03% |
| BAMS, MD | 4 | 12.12% |
| BHMS, MD | 5 | 15.15% |
| BUMS, MD | 1 | 3.03% |
| BSMS, Ph.D | 2 | 6.06% |
| Pharmacist | 1 | 3.03% |
| MPH, Ph.D | 2 | 6.06% |
| Health care settings | ||
| Government hospitals | 22 | 66.66% |
| Private Hospitals | 3 | 9.09% |
| PHCs | 1 | 3.03% |
| Private Clinics | 5 | 15.15% |
| Academics | 2 | 6.06% |
| Working experience in (years) | ||
| 1–10 | 10 | 30.30% |
| 11–20 | 15 | 45.45% |
| >21 | 8 | 24.24% |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Shannawaz, M.; Rathi, I.; Shah, N.; Saeed, S.; Chandra, A. Healthcare Providers’ Perspectives on Telemedicine for NCD Management During and After COVID-19 in India: A Qualitative Study. Int. J. Environ. Res. Public Health 2026, 23, 203. https://doi.org/10.3390/ijerph23020203
Shannawaz M, Rathi I, Shah N, Saeed S, Chandra A. Healthcare Providers’ Perspectives on Telemedicine for NCD Management During and After COVID-19 in India: A Qualitative Study. International Journal of Environmental Research and Public Health. 2026; 23(2):203. https://doi.org/10.3390/ijerph23020203
Chicago/Turabian StyleShannawaz, Mohd, Isha Rathi, Nikita Shah, Shazina Saeed, and Amrish Chandra. 2026. "Healthcare Providers’ Perspectives on Telemedicine for NCD Management During and After COVID-19 in India: A Qualitative Study" International Journal of Environmental Research and Public Health 23, no. 2: 203. https://doi.org/10.3390/ijerph23020203
APA StyleShannawaz, M., Rathi, I., Shah, N., Saeed, S., & Chandra, A. (2026). Healthcare Providers’ Perspectives on Telemedicine for NCD Management During and After COVID-19 in India: A Qualitative Study. International Journal of Environmental Research and Public Health, 23(2), 203. https://doi.org/10.3390/ijerph23020203

